Almirall partners with the Chemical Institute of Sarrià (IQS) to bring pharmacy students’ training closer to real industry

Almirall and the Chemical Institute of Sarria (IQS), educational institution, founding member of the Ramon Llull University (URL) of Barcelona, recently have announced a collaboration agreement that will allow students in the third year of the Bachelor’s degree in Pharmacy URL (IQS – Blanquerna) to carry out for the first time an internship in industrial facilities which meet the real requirements of the industry. The internships will begin in the second term of the 22-23 academic year.

"We are excited to be pioneers in collaborating with institutions such as IQS, a benchmark in science education, and to offer students the opportunity to experience the actual manufacturing process of a drug, which involves a series of procedures and regulations that are difficult to find in the academic environment", said Dr. Karl Ziegelbauer, Chief Scientific Officer of Almirall, who added: "This agreement stems from our desire to open our doors to innovation and share our knowledge of the pharmaceutical industry".

For his part, Dr. Salvador Borrós, general director of IQS, said: "the practical dimension has always been one of the characteristics of IQS's teaching methodology and this agreement reinforces the institution's commitment to training in which innovation and the close relationship between IQS and companies are very present".  

The collaboration establishes the use by students of Pharmacy URL (IQS-Blanquerna) of Almirall's facilities and technologies in its manufacturing area in St. Feliu de Llobregat (Barcelona). The students, who will be completing the internship as a complement to the Pharmaceutical Technology subject, will learn aspects such as the impact on the pharmaceutical form, the different production equipment, the production process, and batch size, among others. In addition, they will also receive training on manufacturing regulations in production environments, which is essential for accessing Almirall's facilities and complying with the Good Manufacturing Practices (GMP) certification.

Almirall's Sant Feliu de Llobregat (Barcelona) centre, inaugurated in 2006, is the company's R&D centre of reference and currently has 7,400 square metres of fully equipped laboratories and production area. This agreement is the first example of the willing of Almirall to offer its facilities to other scientists, biotech and academic institutions and to foster an ecosystem of cutting-edge innovation.

 

Photo: From left to right: Dr. Giorgia Miotto (General Director, Blanquerna), Dr. Karl Ziegelbauer (Chief Scientific Officer, Almirall), Dr. Salvador Borrós Gómez (General Director, IQS), Sonia Amorós Ramos (Director of Administration, IQS)